Search results for "LIVER STEATOSIS"

showing 9 items of 19 documents

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

2023

Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10–25% of the general adult population, 15% of children, and even > 50% of individuals who have type 2 diabetes mellitus. It is a major cause of liver-related morbidity, and cardiovascular (CV) mortality is a common cause of death. In addition to being the initial step of irreversible alterations of the liver parenchyma causing cirrhosis, about 1/6 of those who develop NASH are at risk also developing CV disease (CVD). More recently the acronym MAFLD (Metabolic Associated Fatty Liver Disease) has been preferred by many European and US specialists, providing a clearer message on the metabolic etiology of the dis…

PharmacologySettore MED/04 - Patologia GeneraleNAFLDLiver steatosisPosition paperDietary supplements; Liver steatosis; NAFLD; Nutraceuticals; Position paper;NutraceuticalsDietary supplements
researchProduct

PREVALENCE OF LIVER STEATOSIS AND FIBROSIS AND RELIABILITY OF ULTRASOUND IN DETECTING NAFLD IN OBESE PATIENTS

2018

Background: Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in Western countries, and in particular in obese patients the prevalence is higher than in general population. It has a large clinical spectrum, ranging from simple steatosis to steatohepatitis (NASH) and cirrhosis. Aim of the study: To evaluate in obese patients who underwent bariatric surgery in the last 3 years: 1) the histological prevalence and severity of liver steatosis (LS) and fibrosis; 2) the reliability of ultrasound (US) in diagnosing steatosis. Patients and methods: We reviewed preoperative liver US and intraoperative liver biopsy results in 57 bariatric surgery patients (age 42 ± 1…

Settore MED/09 - Medicina InternaLIVER STEATOSIS FIBROSIS ULTRASOUND NAFLD SEVERE OBESITY BARIATRIC SURGERY
researchProduct

Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line

2023

Non-alcoholic fatty liver disease (NAFLD) is an emerging chronic liver disease worldwide. Curcumin and andrographolide are famous for improving hepatic functions, being able to reverse oxidative stress and release pro-inflammatory cytokines, and they are implicated in hepatic stellate cell activation and in liver fibrosis development. Thus, we tested curcumin and andrographolide separately and in combination to determine their effect on triglyceride accumulation and ROS production, identifying the differential expression of genes involved in fatty liver and oxidative stress development. In vitro steatosis was induced in HepG2 cells and the protective effect of curcumin, andrographolide, and…

lipid dropletsOrganic ChemistryandrographolidePharmaceutical ScienceGKROSAnalytical Chemistryliver steatosisSettore BIO/13 - Biologia ApplicataChemistry (miscellaneous)NAFLDDrug DiscoveryPPARGC1Aliver steatosis.Molecular MedicineFABP1curcuminPhysical and Theoretical ChemistryMolecules
researchProduct

Aknu steatozes saistība ar hroniska pankreatīta gaitu

2019

Ievads. Hronisks pankreatīts ir hroniska iekaisīga aizkuņģa dziedzera slimība, kas var novest līdz eksokrīnai un endokrīnai mazspējai. Literatūrā ir atrodami maz dati par aknu steatozes prevalenci hroniska pankreatīta pacientu vidū, lai gan abām šīm slimībām ir kopīgi etioloģiskie faktori. Darba mērķis. Analizēt aknu steatozes prevalenci HP slimniekiem un novērtēt aknu steatozes asociāciju ar HP smaguma pakāpi un komplikācijām. Metodes un materiāli. Pētījums bija retrospektīvs šķērsgriezuma pētījums. Tajā tika iekļauti pacienti no PSKUS Gastroenteroloģijas, hepatoloģijas un uztura terapijas centra, laika periodā no 2016. gada līdz 2019. gadam. Tika apkopoti tādi klīniskie parametri kā demog…

liver steatosischronic pancreatitisexocrine insufficiencychronic pain syndromeMedicīna
researchProduct

Towards a Rapid Screening of Liver Grafts at the Operating Room Using Mid-Infrared Spectroscopy

2020

The estimation of steatosis in a liver graft is mandatory prior to liver transplantation, as the risk of graft failure increases with the level of infiltrated fat. However, the assessment of liver steatosis before transplantation is typically based on a qualitative or semiquantitative characterization by visual inspection and palpation and histological analysis. Thus, there is an unmet need for transplantation surgeons to have access to a diagnostic tool enabling an in situ fast classification of grafts prior to extraction. In this study, we have assessed an attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopic method compatible with the requirements of an operatio…

medicine.medical_specialtyOperating RoomsGraft failureTime FactorsSpectrophotometry Infraredmedicine.medical_treatmentgraft failureassessmentLiver transplantation010402 general chemistry01 natural sciencesPalpationMid infrared spectroscopyAnalytical Chemistryliver steatosisLiver steatosisstomatognathic systemliver graftmedicinesteatosisHumansmedicine.diagnostic_testliver transplantationChemistryPhysics010401 analytical chemistrymedicine.disease0104 chemical sciences3. Good healthLiver TransplantationLiver graftTransplantationAtomic Molecular and Optical Physicslipids (amino acids peptides and proteins)RadiologySteatosisinfiltrated fat
researchProduct

Focal hepatic intrinsically hyperattenuating lesions at unenhanced CT: Not always calcifications.

2021

Due to the growing use of CT, there has been an increase in the frequency of detecting focal liver lesions. Intrinsically hyperattenuating hepatic lesions or pseudolesions are not uncommon at unenhanced CT. Hyperattenuating hepatic lesions can be divided into non-calcified and calcified. Causes of intrinsic hyperattenuation include hemorrhage, thrombosis, and calcifications. Focal liver lesions can show hyperattenuation on unenhanced CT in case of severe liver steatosis. Recognition of etiologies associated with hyperattenuation on unenhanced CT can help the radiologist in characterizing focal liver lesions and pseudolesions. In this paper, we describe the spectrum of intrinsically hyperatt…

medicine.medical_specialtybusiness.industryHyperattenuating hepatic pseudolesionLiver NeoplasmsCalcinosismedicine.diseaseThrombosisUnenhanced CTHepatic calcified lesionsDiagnosis DifferentialFatty LiverLiver steatosisIntrinsically hyperattenuating hepatic lesionLiver calcificationsmedicineHumansRadiology Nuclear Medicine and imagingRadiologyLiver calcificationsbusinessTomography X-Ray ComputedClinical imaging
researchProduct

Effects of dietary conjugated linoleic acids in the control of adiposity and obesity‐related disorders

2007

The body fat-lowering effect of conjugated linoleic acids (CLA) in experimental animals has attracted much interest because of the potential use of CLA as weight loss agents in humans. The objective of this review was to give an overview of the results from human intervention trials. The review also addresses experimental studies in animal models and in cultured cells. CLA appear to provoke fat mass loss and an increase of fat-free mass in rodents, but the results in humans are inconsistent and much less clear than in rodents. Thus, the results of studies in humans do not support a body fat-lowering effect of CLA. There are indications from animal studies that the trans-10, cis-12 CLA isome…

medicine.medical_specialtymedicine.medical_treatmentLinoleic acidConjugated linoleic acidBiologyIndustrial and Manufacturing Engineeringchemistry.chemical_compoundInsulin resistanceLiver steatosisInternal medicinemedicinechemistry.chemical_classificationintegumentary systemInsulinfood and beveragesGeneral Chemistrymedicine.diseaseObesityEndocrinologyBiochemistrychemistrylipids (amino acids peptides and proteins)Animal studiesFood ScienceBiotechnologyPolyunsaturated fatty acidEuropean Journal of Lipid Science and Technology
researchProduct

Differences between current clinical guidelines for screening, diagnosis and management of non-alcoholic fatty liver disease and real-world practice:…

2021

International audience; INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease and is associated with obesity and metabolic comorbidities. Liver steatosis can progress to nonalcoholic steatohepatitis (NASH) exhibiting a relevant risk of fibrosis and ultimately liver failure. To date, no approved treatment for NASH to reduce its clinical and humanistic burden has been developed. AREAS COVERED: We undertook a literature review to identify English language, national and international clinical guidelines for NAFLD regarding diagnosis, assessment and management, and determined their points of agreement and difference. Additionally, we investigated published liter…

nonalcoholic fatty liver diseaseNonalcoholic steatohepatitismedicine.medical_specialtyliterature review[SDV]Life Sciences [q-bio]Liver fibrosisdigestive systemGastroenterologyDiagnosis DifferentialLiver diseasereal-world practiceLiver steatosisNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseasemedicineHumansMass Screeningnonalcoholic steatohepatitisliver fibrosisHepatologybusiness.industryGastroenterologynutritional and metabolic diseasesfood and beveragesmedicine.diseaseObesitydigestive system diseases[SDV] Life Sciences [q-bio]clinical guidelinesPractice Guidelines as Topicbusiness
researchProduct

Effet anti-obésité des CLA : mythe ou réalité ?

2005

Conjugated linoleic acids (CLA) are positional and geometric isomers of linoleic acid. Inclusion of CLA in the diet provokes a rapid and marked decrease in body weight gain and adiposity in mice leading to a lipoatrophic syndrome. However, CLA supplementation raised fasting blood glucose and insulin concentrations and was associated with severe insulin resistance and liversteatosis. Conflicting results have been reported with regard to reduction of fat mass in humans. We have reviewed the publish literature regarding the effect of CLA on body composition in humans and animal models. These studies indicate that t10-c12 was the isomer that reduced adipose fat storage, however it also increase…

obesitymedicine.medical_specialtymedicine.medical_treatmentConjugated linoleic acidAdipose tissuelcsh:TP670-699BiologyadipocyteBiochemistryliver steatosischemistry.chemical_compoundlipoatrophic diabetesInsulin resistanceInternal medicineAdipocytemedicinelipogenesisUnsaturated fatty acidLipoatrophic diabetesintegumentary systemInsulinFatty liverfood and beveragesmedicine.diseaseEndocrinologychemistrylipids (amino acids peptides and proteins)lcsh:Oils fats and waxesFood ScienceOléagineux, Corps gras, Lipides
researchProduct